NormanBGaylisMD

Rheumatology • Aventura, FL

Clinical Professor, Rheumatology, University of Miami Miller School of Medicine

Join to view full profile

Dr. Gaylis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gaylis' full profile

Already have an account?

Office
2801 NE 213th St
Ste 801
Aventura, FL 33180
Phone+1 305-652-6676

Fax+1 305-932-6335

Summary

Dr. Norman Gaylis is a rheumatologist in Aventura, FL and is affiliated with Aventura Hospital and Medical Center. He received his medical degree from University of the Witwatersrand and has been in practice 44 years. He is experienced in systemic lupus erythematosus, osteoarthritis, rheumatoid arthritis, and gout.

Education & Training

University of Miami/Jackson Health SystemFellowship, Rheumatology, 1979 - 1981
Mount Sinai Medical Center of FloridaResidency, Internal Medicine, 1976 - 1979
University of the WitwatersrandClass of 1973

Certifications & Licensure

FL State Medical License Active through 2025
FL State Medical License 1977 - 2025
GA State Medical License Active through 1979
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

Top Doctors:South Florida Castle Connolly, 2012
Top Doctors: Florida Castle Connolly, 2000
Fellow (FACR) American College of Rheumatology

Clinical Trials

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2007 Feb 01
Completed
Phase 2
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE) Start of enrollment: 2010 Jun 24
Completed
Phase 2
The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients Start of enrollment: 2010 Sep 01
Completed
Phase 3
Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients Start of enrollment: 2011 Jun 01
Completed
Phase 3
The Effect of Corticotrophin (ACTH) in Combination With Methotrexate in Newly Diagnosed Rheumatoid Arthritis Patients Start of enrollment: 2013 Sep 01
Completed
Phase 4
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
Completed
Phase 3
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

411 citations
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-bli...
Josef S Smolen, Jonathan Kay, Mittie K. Doyle, Robert Landewé, Eric L. Matteson
Lancet. 2009-07-18
44 citations
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a re...
Paul Emery, Philip J. Mease, Andrea Rubbert-Roth, Jeffrey R. Curtis, Ulf Müller-Ladner
Rheumatology. 2011-09-16
9 citations
Patient Perspectives on Intravenous Biologics for Rheumatologic Disease.
Lucas Grisanti, Alysia Kwiatkowski, Peter Dyrda, Ellen Field, Joseph Grisanti
Arthritis Care & Research. 2019-09-01

Press Mentions

COVID-19 Nasal Spray Shows Strong Immune Response in StudyApril 7th, 2023
COVID Vaccine Nasal Spray Shows Strong Immune Response in Study: ‘Could Be a Game Changer’April 6th, 2023
5 Questions to Ask Your Doctor for a COVID-19 Treatment Strategy (Before Infection)April 3rd, 2023
Join now to see all

Professional Memberships

American College of Rheumatology - ACR
Fellow